Deniz Doğan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Deniz Doğan has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Ahmet Özaslan
Department of Child and Adolescent Psychiatry, Faculty of Medicine, Gazi University, Ankara, Turkey
1 shared publication - Aybeniz Civan Kahve
Department of Psychiatry, Faculty of Medicine, Gazi University, Türkiye
1 shared publication - Dicle Buyuktaskin
Department of Child and Adolescent Psychiatry Faculty of Medicine Gazi University Ankara Türkiye
1 shared publication Elvan İşEri
Department of Child and Adolescent Psychiatry Faculty of Medicine Gazi University Ankara Türkiye
1 shared publicationEsra Kara Aşkın
Department of Child and Adolescent Psychiatry Faculty of Medicine Gazi University Ankara Türkiye
1 shared publicationGizem Yaz Aydın
Department of Biochemistry Faculty of Medicine Gazi University Ankara Türkiye
1 shared publication
Latest Publications
- 16 October 2026
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 41 (6) , e70068
Serum Tau and α‐Synuclein in Children With Attention‐Deficit/Hyperactivity Disorder: Cross‐Sectional Associations With Methylphenidate Treatment
Objective: To compare serum total tau and α‐synuclein among controls, drug‐naïve children with attention‐deficit/hyperactivity disorder (ADHD) and children with ADHD receiving methylphenidate. Methods: Original ELISA spreadsheets provided 26 controls, 29 evaluable drug‐naïve participants and 32 methylphenidate‐treated participants. Boundary‐coded results (> 500 pg/mL for tau; < 938 pg/mL for α‐synuclein) were assigned the recorded boundary for rank‐based analyses. Groups were compared using Kruskal–Wallis tests and Dunn–Bonferroni contrasts; within‐group associations used Spearman correlations. Results: α‐Synuclein differed among groups ( H = 49.859, p < 0.001, ε 2 = 0.570), with all pairwise contrasts significant. Tau also differed ( H = 10.492, p = 0.005, ε 2 = 0.101); drug‐naïve ADHD had lower tau than controls, whereas the treated group differed from neither comparator after correction. The α‐synuclein–tau correlation remained significant after false‐discovery‐rate adjustment only in drug‐naïve ADHD ( ρ = 0.443, adjusted p = 0.048). Conclusions: Serum α‐synuclein and total tau showed distinct cross‐sectional group patterns. These associations do not establish methylphenidate effects and require prospective confirmation.
- 16 October 2026
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 41 (6) , e70068
Serum Tau and α‐Synuclein in Children With Attention‐Deficit/Hyperactivity Disorder: Cross‐Sectional Associations With Methylphenidate Treatment
Objective: To compare serum total tau and α‐synuclein among controls, drug‐naïve children with attention‐deficit/hyperactivity disorder (ADHD) and children with ADHD receiving methylphenidate. Methods: Original ELISA spreadsheets provided 26 controls, 29 evaluable drug‐naïve participants and 32 methylphenidate‐treated participants. Boundary‐coded results (> 500 pg/mL for tau; < 938 pg/mL for α‐synuclein) were assigned the recorded boundary for rank‐based analyses. Groups were compared using Kruskal–Wallis tests and Dunn–Bonferroni contrasts; within‐group associations used Spearman correlations. Results: α‐Synuclein differed among groups ( H = 49.859, p < 0.001, ε 2 = 0.570), with all pairwise contrasts significant. Tau also differed ( H = 10.492, p = 0.005, ε 2 = 0.101); drug‐naïve ADHD had lower tau than controls, whereas the treated group differed from neither comparator after correction. The α‐synuclein–tau correlation remained significant after false‐discovery‐rate adjustment only in drug‐naïve ADHD ( ρ = 0.443, adjusted p = 0.048). Conclusions: Serum α‐synuclein and total tau showed distinct cross‐sectional group patterns. These associations do not establish methylphenidate effects and require prospective confirmation.